anonymous
Guest
anonymous
Guest
r*****? You OBU REPS can't even give Xiidra away all I have to say is $57 million in Q2. You OBU reps are killing it.' You should be cheering us NBU reps on, our coupon & MC drops are paying your over paid salaries. And that is a fact. The OBU reps stink so bad that PS had to get rid of some Of the smell. Vyvanse is a $2 billion+ drug built in a highly generic therapeutic class, not the easy beeezing area you are in. We don't have samples to get signitures for we have to fight to get access. You should show some gratitude for the job the NBU provided you.
NBU-gaining access despite extremely poor grammar and spelling skills.